Celanese Corporation

Celanese Corporation Earnings Recaps

CE Materials 3 recaps
Next earnings: February 16, 2027 (estimated) · full calendar
Q3 2026 Nov 4, 2026

Celanese shares rose 5.0% after earnings, signaling a positive market response. Investors appear to have welcomed management’s confidence in generating $700–$800 million of free cash flow next year and continued momentum in electronics and healthcare.

Key takeaways
  • Management reiterated a **$700–$800 million free cash flow** range for next year, citing limited need to raise capital spending and opportunities to improve working capital.
  • The company expects to shift about **$100 million of costs and interest** into next year, while restructuring cash outlays are expected to decline by **$30–$40 million**.
  • Celanese sees electronics and medical continuing as growth areas into 2027, while acknowledging tougher comparisons after strong performance this year.
  • In Acetyl Chain, management sees further opportunity in downstream emulsions and powders; any needed investment would remain within its stated **$300–$350 million** capital range.
Q1 2026 May 7, 2026

The stock dropped 15.4% following the quarter as investors reacted negatively to a cautious outlook and signs of demand weakness across major end markets, undermining confidence in the company’s near-term growth prospects.

Key takeaways
  • Management acknowledged weak demand across key end markets, with only transient uplift from order pattern distortions (prebuys) in Q1.
  • The guidance for the second half assumes supply chain normalization and a moderate recovery in volumes and margins, reflecting continued uncertainty.
  • Despite operating some assets at high utilization (Clear Lake), supply chain challenges and cautious capacity ramp-ups highlight ongoing execution risks.
  • Engineered Materials segment shows resilience with pricing actions to offset feedstock inflation, but feedthrough delays persist.
  • Equity earnings from benzene-related operations are expected to remain flat versus last year, constrained by recent shutdowns and shipping disruptions.
Q2 2025 Aug 12, 2025

Celanese Corporation reported a mixed performance in Q2 2025, with EPS impacted by weakening demand in key markets, particularly in China and Europe, despite maintaining strong free cash flow projections.

Key takeaways
  • Q2 EPS guidance reinforced at $1.25, but demand weakening may delay reaching the $2 per share target.
  • Significant inventory reduction efforts resulted in a projected $25 million negative earnings impact in Q3 from Engineered Materials.
  • Free cash flow remains a top priority, with expectations set at $700 million to $800 million for the year, translating to approximately $7 per share.
  • Continued plans for cost structure improvements and price optimization in distinct market segments are in place to enhance profitability.
  • Stability noted in the Americas market despite global demand challenges, indicating potential resilience in some regional operations.